N-Acetylornithine
博飞美科提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载
PA71688
PERFEMIKER
6205-08-9
C7H14N2O3
174.20
*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!
| 产品名称： |
N-Acetylornithine,98% |
| 中文别名： |
N-乙酰-L-鸟氨酸;(S)-2-乙酰氨基-5-氨基戊酸;Nalpha-乙酰基-L-鸟氨酸 |
| 英文名称： |
N-Acetylornithine |
| 英文别名： |
n-alpha-acetyl-l-ornithine;Ac-Orn-OH;N-ACETYL-L-ORN;Nα-Acetyl-L-ornithine;(2S)-2-acetamido-5-aminopentanoic acid;A-Acetyl-L-ornithine;ACETYL-L-ORNITHINE;AOR;N(2)-acetyl-L-ornithine;N-acetylornithine;Ornithine,N2-acetyl;N-Acetyl-L-ornithine;N2-Acetyl-L-ornithine;acetylornithine;Na-Acetyl-L-ornithine;N~2~-ACETYL-L-ORNITHINE;Ac-OM-OH;Ornithine, N2-acetyl-;Nalpha-Acetyl-L-ornithine;acetyl-ornithine;N;bmse000195;JRLGPAXAGHMNOL-LURJTMIESA-N;6104AH;(2S)-2-acetamido-5-aminopentanoate;AK;N-Acetylornithine |
| 品牌： |
PERFEMIKER |
| CAS号： |
6205-08-9 |
| 分子式： |
C7H14N2O3 |
| 分子量： |
174.20 |
| 纯度： |
98% |
| 详细描述： |
博飞美科的N-Acetylornithine,98%为抑制剂,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为50mg。查询关键词:抑制剂，6205-08-9，N-Acetylornithine,98%，N-Acetylornithine，博飞美科，Perfemiker，上海，厂家直销。 |
沪公网安备31011402010658号 
C(%5bH%5d)(%5bH%5d)%5bC%40%40%5d(C(%5bH%5d)(%5bH%5d)%5bH%5d)(%5bC%40%5d(%5bH%5d)(%5bC%40%5d(%5bH%5d)(C(%5bH%5d)(%5bH%5d)%5bH%5d)O1)OC(C(%5bH%5d)(%5bH%5d)%5bH%5d)%3dO)O%5bH%5d)%5bC%40%40%5d1(%5bH%5d)%5bC%40%40%5d(%5bH%5d)(%5bC%40%40%5d(%5bH%5d)(C(%5bH%5d)(%5bH%5d)%5bH%5d)O%5bC%40%5d(%5bH%5d)(C1(%5bH%5d)%5bH%5d)O%5bC%40%40%5d1(%5bH%5d)%5bC%40%40%5d(%5bH%5d)(%5bC%40%40%5d(%5bH%5d)(C(%5bH%5d)(%5bH%5d)%5bH%5d)O%5bC%40%5d(%5bH%5d)(C1(%5bH%5d)%5bH%5d)O%5bC%40%5d1(%5bH%5d)C(C2C(%3dC3C(%3dC(C(%5bH%5d)(%5bH%5d)%5bH%5d)C(%3dC(%5bH%5d)C3%3dC(%5bH%5d)C%3d2C(%5bH%5d)(%5bH%5d)%5bC%40%40%5d1(%5bH%5d)%5bC%40%40%5d(%5bH%5d)(C(%5bC%40%5d(%5bH%5d)(%5bC%40%40%5d(%5bH%5d)(C(%5bH%5d)(%5bH%5d)%5bH%5d)O%5bH%5d)O%5bH%5d)%3dO)OC(%5bH%5d)(%5bH%5d)%5bH%5d)O%5bC%40%40%5d1(%5bH%5d)C(%5bH%5d)(%5bH%5d)%5bC%40%5d(%5bH%5d)(%5bC%40%5d(%5bH%5d)(%5bC%40%40%5d(%5bH%5d)(C(%5bH%5d)(%5bH%5d)%5bH%5d)O1)OC(C(%5bH%5d)(%5bH%5d)%5bH%5d)%3dO)O%5bC%40%5d1(%5bH%5d)C(%5bH%5d)(%5bH%5d)%5bC%40%5d(%5bH%5d)(%5bC%40%5d(%5bH%5d)(%5bC%40%40%5d(%5bH%5d)(C(%5bH%5d)(%5bH%5d)%5bH%5d)O1)OC(%5bH%5d)(%5bH%5d)%5bH%5d)O%5bH%5d)O%5bH%5d)O%5bH%5d)%3dO)O%5bH%5d)O%5bH%5d)
C%3d2)F)%3dO)%5bC%40H%5d1C1C%3dNC%3dCC%3d1)%3dO)(F)F)
%3dO)C(COC(CCCC%2fC%3dC%5cC%2fC%3dC%5cC%2fC%3dC%5cCCCCC)%3dO)COC(CCCC%2fC%3dC%5cC%2fC%3dC%5cC%2fC%3dC%5cCCCCC)%3dO)
O)O)C%2fC%3dC%5cCCC(%3dO)OC)